GL1X · GenesisL1 explorer

MolNFT v1 · #106014 · protein

Biochemical and structural characterization of mycobacterial aspartyl- tRNA synthetase asps, a promising tb drug target

4RMF · Aspartate--TRNA(ASP/ASN) ligase: “Biochemical and structural characterization of mycobacterial aspartyl- tRNA synthetase asps, a promising tb…”. X-ray diffraction, 1 ligand (3SY), 6 pockets (best druggability 0.73). MolNFT v1…

PDB
4RMF
Type
protein
Length
579 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aspartate--TRNA(ASP/ASN) ligase
EC
6.1.1.23
UniProt
A0QWN3
Ligands
3SY
Pockets
6 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAspartate--TRNA(ASP/ASN) ligase (EC 6.1.1.23)protein57931% helix, 25% strandA0QWN3

Ligands and binding sites

  • 3SY · 2,2-bis(hydroxymethyl)propane-1,3-diol · ligand · chains A
  • FMT · Formic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17140.730.7959FMT
2940.400.7724empty
31360.380.7324empty
4780.340.7518empty
5570.290.7416empty

Compared structures

  • 4RMF · Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase… · the same entry in another collection · chain A against A, TM-score 1.00
  • A0QWN3 · AlphaFold monomer V2.0 prediction for aspartate--TRNA(ASP/ASN) ligase (A0QWN3) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.